ruxolitinib
incyte,novartis
['jakafi']
palandri: great presentation summarizing challenges in managing mf with cytopenia, outcome post jakafi failure, treatment combination with jaki to counter myelosuppression/halting progression. #eha23 #eha2023 
Assistant Professor @MayoCancerCare Alumni @MDAndersonNews. Interest: Acute Leukemia & myeloid disorders Passionate about 🇵🇰cricket 🏏 foodie.Views are my own